Literature DB >> 1624595

Comparison of relative uses of commercial assays for Toxoplasma gondii IgM antibodies.

D Ashburn1, R Evans, L J Skinner, J M Chatterton, A W Joss, D O Ho-Yen.   

Abstract

AIMS: To compare the sensitivity and user friendliness of seven commercially available enzyme linked immunoabsorbent assay (ELISA) kits for toxoplasma specific IgM.
METHODS: Five antibody capture assays supplied by Abbott, Mercia, Northumbria, Organon and Sorin, and two indirect ELISA assays from Biostat and Mast, were assessed. Using defined dilutions of Toxoplasma gondii specific IgM, the performance and sensitivity of each assay was established. They were further assessed on a panel of 27 sera with a range of dye test and IgM results (as determined by the Scottish Toxoplasma Reference Laboratory). All of the assays were performed by three experienced operators and assessed for user satisfaction.
RESULTS: The Mast, Organon, and Abbott assays were of low sensitivity; the Mercia and Northumbria were of high sensitivity; and the Biostat and Sorin assays produced too many false positive results. The Mercia kit provided most user satisfaction; the Mast and Abbott assays were most difficult to use.
CONCLUSIONS: Local laboratories investigating toxoplasma infection should have three tests: one IgG and two IgM (high and low sensitivity) to help in the timing of infection. Alternatively, one sensitive IgM assay, such as that of Mercia, could be used by selecting appropriate high and low thresholds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624595      PMCID: PMC495219          DOI: 10.1136/jcp.45.6.483

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii.

Authors:  C Verhofstede; L Van Renterghem; J Plum
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

2.  Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii.

Authors:  P Herbrink; A M van Loon; J P Rotmans; F van Knapen; W C van Dijk
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

3.  Public Health Laboratory Service enzyme linked immunosorbent assay for detecting Toxoplasma specific IgM antibody.

Authors:  R A Payne; D H Joynson; A H Balfour; J P Harford; D G Fleck; M Mythen; R J Saunders
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

4.  Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody.

Authors:  D H Joynson; R A Payne; A H Balfour; E S Prestage; D G Fleck; B S Chessum
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

5.  Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies.

Authors:  F Wielaard; H van Gruijthuijsen; W Duermeyer; A W Joss; L Skinner; H Williams; E H van Elven
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

6.  Biotin-labelled antigen screening test for toxoplasma IgM antibody.

Authors:  A W Joss; L J Skinner; I L Moir; J M Chatterton; H Williams; D O Ho-Yen
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

7.  The use of an IgM immunosorbent agglutination assay to diagnose congenital toxoplasmosis.

Authors:  L J Skinner; J M Chatterton; A W Joss; I L Moir; D O Ho-Yen
Journal:  J Med Microbiol       Date:  1989-02       Impact factor: 2.472

  7 in total
  6 in total

1.  Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems.

Authors:  W T Hofgärtner; S R Swanzy; R M Bacina; J Condon; M Gupta; P E Matlock; D L Bergeron; J J Plorde; T R Fritsche
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

2.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis.

Authors:  O Liesenfeld; C Press; R Flanders; R Ramirez; J S Remington
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  The Vitek immunodiagnostic assay for detection of immunoglobulin M toxoplasma antibodies.

Authors:  E Candolfi; R Ramirez; M P Hadju; C Shubert; J S Remington
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

5.  Specificity and usefulness of an IgE immunosorbent agglutination assay for toxoplasmosis.

Authors:  D Ashburn; A W Joss; T H Pennington; D O Ho-Yen
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

6.  Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy?

Authors:  D Ashburn; A W Joss; T H Pennington; D O Ho-Yen
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.